updating data for batch codes

docs/SymptomsCausedByDrugs/data/ProportionalReportingRatios/vaccines/156.json

@@ -1 +1 @@
-{"abdominal pain upper": 2.64, "acute phase reaction": 1229.66, "arthralgia": 2.01, "atypical femur fracture": 866.39, "atypical fracture": 1067.92, "back pain": 5.08, "blood parathyroid hormone increased": 19.98, "bone disorder": 8.3, "bone pain": 19.35, "chest pain": 2.41, "compression fracture": 23.79, "dental caries": 9.79, "dyspepsia": 3.07, "emotional distress": 3.11, "exposed bone in jaw": 157.67, "extravasation": 14.35, "fall": 2.65, "femoral neck fracture": 22.83, "femur fracture": 63.13, "flatulence": 2.42, "foot fracture": 4.81, "fracture": 9.27, "gastric haemorrhage": 4.32, "gastric ulcer": 3.13, "gastritis": 6.91, "gastrointestinal disorder": 2.52, "gastrooesophageal reflux disease": 2.05, "gingivitis": 11.37, "groin pain": 5.13, "hip fracture": 4.8, "hypercalcaemia": 6.42, "hypocalcaemia": 10.21, "impaired healing": 8.35, "influenza like illness": 3.19, "infusion site extravasation": 14.26, "injection site extravasation": 10.26, "jaw disorder": 25.62, "loose tooth": 31.98, "low turnover osteopathy": 827.26, "lower limb fracture": 5.34, "movement disorder": 3.87, "musculoskeletal chest pain": 3.69, "musculoskeletal pain": 6.06, "musculoskeletal stiffness": 2.85, "oesophageal ulcer": 14.74, "oesophagitis": 21.74, "osteitis": 52.28, "osteoarthritis": 2.49, "osteomyelitis": 46.85, "osteonecrosis": 12.72, "osteonecrosis of jaw": 473.62, "pain in jaw": 12.54, "pathological fracture": 37.24, "periodontitis": 54.97, "phlebitis": 5.97, "product administration error": 4.38, "rib fracture": 4.6, "spinal compression fracture": 14.05, "spinal fracture": 7.01, "spinal pain": 6.0, "stress fracture": 105.31, "tooth disorder": 7.67, "tooth extraction": 61.7, "tooth fracture": 10.45, "tooth loss": 2.62, "toothache": 6.7}
+{"abdominal abscess": 24.29, "abnormal behaviour": 3.76, "acute kidney injury": 2.81, "acute lymphocytic leukaemia": 19.07, "acute myeloid leukaemia": 4.99, "acute respiratory distress syndrome": 5.03, "agranulocytosis": 3.04, "anaemia": 2.85, "brain oedema": 5.04, "bronchopulmonary aspergillosis": 8.67, "candida infection": 7.73, "cardiac failure": 2.0, "cardiogenic shock": 5.23, "clostridium difficile infection": 5.68, "cytomegalovirus infection": 4.22, "cytomegalovirus infection reactivation": 17.47, "cytopenia": 15.03, "disease progression": 5.58, "drug eruption": 3.41, "drug ineffective": 2.39, "drug ineffective for unapproved indication": 6.47, "drug intolerance": 2.75, "drug reaction with eosinophilia and systemic symptoms": 4.65, "drug resistance": 5.06, "enterococcal infection": 25.67, "febrile neutropenia": 8.71, "haematotoxicity": 7.0, "hepatitis b reactivation": 15.53, "hypercalcaemia": 9.17, "hypogammaglobulinaemia": 15.12, "hypokalaemia": 2.4, "hypoxia": 2.05, "ileus paralytic": 16.84, "infection": 4.73, "infusion related reaction": 4.23, "intentional product misuse": 2.72, "intentional product use issue": 2.8, "klebsiella infection": 26.72, "leukopenia": 3.11, "lower respiratory tract infection": 2.47, "lymphopenia": 5.67, "malignant neoplasm progression": 2.05, "metapneumovirus infection": 101.34, "mucosal inflammation": 8.08, "multiple organ dysfunction syndrome": 3.78, "myelodysplastic syndrome": 8.98, "myelosuppression": 6.8, "neuropathy peripheral": 17.96, "neurotoxicity": 5.75, "neutropenia": 6.69, "neutrophil count decreased": 2.19, "off label use": 3.4, "pancytopenia": 6.6, "paranoia": 7.52, "peripheral sensory neuropathy": 44.3, "plasma cell leukaemia": 219.6, "plasma cell myeloma": 140.86, "plasma cell myeloma recurrent": 169.46, "plasma cell myeloma refractory": 388.58, "plasmacytoma": 137.14, "platelet count decreased": 2.97, "pneumonia": 3.55, "polyneuropathy": 26.64, "polyomavirus-associated nephropathy": 39.73, "posterior reversible encephalopathy syndrome": 18.43, "product use in unapproved indication": 5.02, "progressive multifocal leukoencephalopathy": 14.46, "pulmonary oedema": 2.81, "renal impairment": 2.11, "respiratory failure": 2.62, "respiratory tract infection": 3.92, "sepsis": 5.87, "septic shock": 4.85, "shock": 3.5, "staphylococcal bacteraemia": 28.12, "staphylococcal sepsis": 18.25, "therapeutic product effect incomplete": 6.32, "therapeutic response decreased": 6.76, "therapy non-responder": 10.88, "therapy partial responder": 20.5, "thrombocytopenia": 7.81, "thrombotic microangiopathy": 13.13, "treatment failure": 5.41, "tumour lysis syndrome": 21.9, "vascular device infection": 17.57, "white blood cell count decreased": 2.31}